Difficulty: Medium
Average Score: 79%
Practice
Regarding the recently introduced lipid formulation of amphotericin B, which one of the following statements is accurate?
Correct answer
D
Rationale
The correct answer is D) They may decrease nephrotoxicity of amphotericin B.
Rationale:
The lipid formulation of amphotericin B has been developed to reduce the nephrotoxicity associated with conventional amphotericin B. By incorporating amphotericin B into lipid molecules, the drug is believed to be better tolerated by patients, leading to reduced kidney damage. This formulation allows for a slower release of the drug, potentially decreasing its toxicity to the kidneys.
Option A is incorrect because amphotericin B's primary mode of action is binding to ergosterol in fungal cell membranes, not to the lipids of the formulation. Option B is incorrect as lipid formulations are generally more expensive due to the added technology involved. Option C is incorrect because the primary benefit of lipid formulations is not increased tissue uptake but rather reduced toxicity.
Educational Context:
Understanding the rationale behind the development of lipid formulations of drugs like amphotericin B is crucial for healthcare professionals. It highlights the importance of drug delivery systems in minimizing adverse effects and improving patient outcomes. By grasping these concepts, healthcare providers can make informed decisions when selecting appropriate treatment options for patients with fungal infections, taking into consideration both efficacy and safety profiles.
Rationale:
The lipid formulation of amphotericin B has been developed to reduce the nephrotoxicity associated with conventional amphotericin B. By incorporating amphotericin B into lipid molecules, the drug is believed to be better tolerated by patients, leading to reduced kidney damage. This formulation allows for a slower release of the drug, potentially decreasing its toxicity to the kidneys.
Option A is incorrect because amphotericin B's primary mode of action is binding to ergosterol in fungal cell membranes, not to the lipids of the formulation. Option B is incorrect as lipid formulations are generally more expensive due to the added technology involved. Option C is incorrect because the primary benefit of lipid formulations is not increased tissue uptake but rather reduced toxicity.
Educational Context:
Understanding the rationale behind the development of lipid formulations of drugs like amphotericin B is crucial for healthcare professionals. It highlights the importance of drug delivery systems in minimizing adverse effects and improving patient outcomes. By grasping these concepts, healthcare providers can make informed decisions when selecting appropriate treatment options for patients with fungal infections, taking into consideration both efficacy and safety profiles.